| Isoproterenol induces primary loss of dystrophin in rat hearts: correlation with myocardial injury. | |
| | |
MedLine Citation:
|
PMID: 18808529 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The mechanism of isoproterenol-induced myocardial damage is unknown, but a mismatch of oxygen supply vs. demand following coronary hypotension and myocardial hyperactivity is the best explanation for the complex morphological alterations observed. Severe alterations in the structural integrity of the sarcolemma of cardiomyocytes have been demonstrated to be caused by isoproterenol. Taking into account that the sarcolemmal integrity is stabilized by the dystrophin-glycoprotein complex (DGC) that connects actin and laminin in contractile machinery and extracellular matrix and by integrins, this study tests the hypothesis that isoproterenol affects sarcolemmal stability through changes in the DGC and integrins. We found different sensitivity of the DGC and integrin to isoproterenol subcutaneous administration. Immunofluorescent staining revealed that dystrophin is the most sensitive among the structures connecting the actin in the cardiomyocyte cytoskeleton and the extracellular matrix. The sarcomeric actin dissolution occurred after the reduction or loss of dystrophin. Subsequently, after lysis of myofilaments, gamma-sarcoglycan, beta-dystroglycan, beta1-integrin, and laminin alpha-2 expressions were reduced followed by their breakdown, as epiphenomena of the myocytolytic process. In conclusion, administration of isoproterenol to rats results in primary loss of dystrophin, the most sensitive among the structural proteins that form the DGC that connects the extracellular matrix and the cytoskeleton in cardiomyocyte. These changes, related to ischaemic injury, explain the severe alterations in the structural integrity of the sarcolemma of cardiomyocytes and hence severe and irreversible injury induced by isoproterenol. |
| | |
Authors:
|
Erica C Campos; Minna M D Romano; Cibele M Prado; Marcos A Rossi |
Related Documents
:
|
3567459 - Effects of morphine on cardiovascular responses to acute myocardial ischaemia in rats. 19902059 - Comparative assessment of heart remodeling in rats after experimental coronary stenosis... 9136669 - Reflex adrenal medullary secretion during coronary occlusion mediated by cardiac recept... 10644599 - Structural and mechanical factors influencing infarct scar collagen organization. 3941199 - Effect of exercise on acute myocardial infarction in rats. 10703689 - Nitric oxide synthase ii mrna expression in cardiac tissue of patients with heart failu... 20143209 - Grown-up kawasaki disease patients who have giant coronary aneurysms. 8957369 - Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dos... 15732029 - Managed care patients with heart failure: spectrum of ventricular dysfunction and predi... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: International journal of experimental pathology Volume: 89 ISSN: 1365-2613 ISO Abbreviation: Int J Exp Pathol Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-09-23 Completed Date: 2008-12-04 Revised Date: 2011-12-21 |
Medline Journal Info:
|
Nlm Unique ID: 9014042 Medline TA: Int J Exp Pathol Country: England |
Other Details:
|
Languages: eng Pagination: 367-81 Citation Subset: IM |
Affiliation:
|
Department of Pathology (Cellular and Molecular Cardiology), Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Actins
/
analysis,
metabolism Adrenergic beta-Agonists / adverse effects* Animals Antigens, CD29 / analysis Apoptosis Cardiomyopathies / chemically induced*, immunology, metabolism Dystroglycans Dystrophin / analysis*, metabolism Echocardiography Fluorescent Antibody Technique Isoproterenol / adverse effects* Laminin / analysis, metabolism Macrophages / immunology Male Myocardium / immunology, metabolism*, pathology Nitric Oxide Synthase Type III / analysis Rats Sarcoglycans / analysis, metabolism Sarcolemma / chemistry, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Actins; 0/Adrenergic beta-Agonists; 0/Antigens, CD29; 0/Dystrophin; 0/Laminin; 0/Sarcoglycans; 0/laminin alpha 2; 146888-27-9/Dystroglycans; 7683-59-2/Isoproterenol; EC 1.14.13.39/Nitric Oxide Synthase Type III |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adverse effect of the anabolic-androgenic steroid mesterolone on cardiac remodelling and lipoprotein...
Next Document: L-arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and r...